Hongbing Cai - Concepedia

Author

Hongbing Cai

Also Known As

CAI Hongbing, H Cai, H. CAI, H.B. Cai, HONGBING CAI, Han‐qin Cai, Hong-Bing Cai, Hong-bing Cai, Hongbing Cai, Hongning Cai

104

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Wuhan University Zhongnan Hospital of Wuhan University Hubei Cancer Hospital Southern Medical University Sun Yat-sen University

About

Hongbing Cai is an author at Wuhan University specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	553
2	Health Sciences	2	2	92
3	Natural Sciences	2	2	99
4	Public Health	2	2	73
5	Engineering	1	1	29

Hongbing Cai

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak Mengyuan Dai, Dianbo Liu, Miao Liu, Cancer Discovery	2020	1.6K
RETRACTED ARTICLE: Epstein–Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma Longmei Cai, Yanfen Ye, Qiang Jiang, Nature Communications	2015	212
TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness Xiaoming Lyu, Weiyi Fang, Longmei Cai, Molecular Cancer	2014	124
Base mispair extension kinetics. Binding of avian myeloblastosis reverse transcriptase to matched and mismatched base pair termini. Steven Creighton, Miller Huang, Hongbing Cai, Journal of Biological Chemistry GeneticsMolecular BiologyEnzymatic ModificationTranscriptional RegulationDna Polymerase	1992	80
Knowledge, attitude, practice and barriers of cervical cancer screening among women living in mid-western rural, Nepal Niresh Thapa, Muna Maharjan, Marcia A. Petrini, Journal of Gynecologic Oncology	2018	79
MiR-195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclin D1 Zhen Li, Hua Wang, Zhiqiang Wang, Tumor Biology	2015	74
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China Xiaohua Wu, Yang Sun, Hongying Yang, The Lancet Metastatic Cervical CancerCervical CancerPlacebo-controlled Phase 3MedicineClinical Trials	2024	73
Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteria Ting Hu, Shuang Li, Yile Chen, European Journal of Cancer	2012	70
Curcumin enhances the radiosensitivity in nasopharyngeal carcinoma cells involving the reversal of differentially expressed long non-coding RNAs Qirui Wang, Haoning Fan, Ying Liu, International Journal of Oncology Cancer ResearchOncologyLncrna ProfilesOncogenic AgentMedicine	2013	68
Impact of cervical cancer on quality of life of women in Hubei, China Niresh Thapa, Muna Maharjan, Yan Xiong, Scientific Reports	2018	64

Page 1